Front Row Lecture Series

Scripps Research scientists working at the leading edge of the COVID-19 pandemic share their latest discoveries about this deadly coronavirus directly with viewers. Join each virtual lecture from the comfort and safety of your home and stay up to date on current scientific knowledge, the status of developmental vaccines and medicines, and strategies for the future of public health. Register for free by clicking on the buttons below. Questions? Please contact frontrow@scripps.edu

Andersen Headshot
Wednesday, April 15, 2020
1:00 p.m. PT/4:00 p.m. ET
register ▶

"Outsmarting Emerging Pathogens in an Interconnected World"

At the beginning of the COVID-19 pandemic, Kristian Andersen, PhD, a genomic epidemiologist, was one of the first to begin tracing the origins and spread of the novel coronavirus based on public genome sequencing data. In this virtual Front Row lecture, Andersen will share unique insights on how the COVID-19 pandemic emerged and spread around the world, as well as what science tells us has worked and not worked to mitigate the public health crisis. He’ll discuss how the lessons learned from the current pandemic and other infectious disease epidemics can help us prepare for future outbreaks.

SPEAKER INFORMATION:

Kristian Andersen, PhD
Professor
Department of Immunology & Microbiology
Scripps Research

Farzan Headshot
Wednesday, April 22, 2020
1:00 p.m. PT/4:00 p.m. ET
Register ▶

"Addressing the Coronavirus Challenge"

How do scientists make vaccines and drugs against a germ that simply didn’t exist months ago? Hear a progress report from one of the world’s leading coronavirus experts now responding to the current global health crisis. Virologist Michael Farzan of Scripps Research, Florida and colleagues are developing vaccine and antiviral medicine candidates to protect against the novel coronavirus strain causing COVID-19. You won’t want to miss these insights into how a virus so similar to SARS became so contagious and deadly.

SPEAKER INFORMATION:

Michael Farzan, PhD
Professor and Co-Chair
Department of Immunology & Microbiology
Scripps Research

Chatterjee Headshot
Wednesday, May 6, 2020
1:00 p.m. PT/4:00 p.m. ET
register ▶

"Leveraging the World’s Leading Drug Repurposing Collection Against COVID-19"

In this virtual Front Row lecture, Arnab Chatterjee, PhD, will share how scientists at Calibr, the drug development division of Scripps Research, are taking a unique approach to searching for anti-viral drugs against the novel coronavirus causing the COVID-19 pandemic. Working with collaborators around the globe, they are leveraging ReFRAME, the world’s leading collection of known drugs, to find anti-viral compounds that could be repurposed to treat the disease on a much quicker timescale than therapies developed from scratch. Already, they are making progress in identifying promising drug candidates with potential for helping people who contract COVID-19.

SPEAKER INFORMATION:

Arnab Chatterjee, PhD
Vice President, Medicinal Chemistry
Calibr at Scripps Research

Burton Headshot
Wednesday, May 20, 2020
1:00 p.m. PT/4:00 p.m. ET
register ▶

"Survivors of Coronavirus Infections May Hold the Secret to Stopping COVID-19"

Soon after the COVID-19 pandemic reached the United States, a team of Scripps Research scientists began studying blood samples from patients recovering from infection by the novel coronavirus. In this virtual Front Row lecture, Dennis Burton, PhD, will share how he and his collaborators are analyzing COVID-19 survivors' blood for proteins, known as antibodies, that the immune system creates after encountering the virus. Antibodies to the new coronavirus could be used as much-needed therapeutics to COVID-19 or to help design a vaccine to protect against the disease.

SPEAKER INFORMATION:

Dennis Burton, PhD
Professor and Co-Chair
Department of Immunology & Microbiology
Scripps Research

California Campus

Advancing Precision Medicines to Stop Cancer, ALS, Muscular Dystrophy – and Coronavirus
Innovative chemist Matthew Disney, PhD, delivers the first pandemic edition of the popular Scripps Research Front Row lectures, via webinar. Watch as he describes his unique drug-discovery tools, now revealing new ways of attacking the RNA virus that causes COVID-19. Rather than targeting proteins, as most drugs do, Disney spent a decade developing an effective way to target RNAs involved in genetic diseases like ALS and cancer. That’s proving important as the novel coronavirus spreads globally.

Presented: March 18, 2020

 

New Understanding of Brain Diseases: Toward Disease-Modifying Therapies
Alzheimer’s, Lewy-body dementia, fronto-temporal dementia, Parkinson’s and ALS appear to be very different diseases, yet they share something striking in common: an accumulation of “aggregates” or toxic, misfolded proteins. Professor Lasmézas is an authority on neurological diseases that are caused by protein misfolding and her lab is working on potential treatments for these diseases as well as prion diseases including Creutzfeldt-Jacob disease (CJD).

Presented: February 19, 2020

 

A New Model for Biomedical Research
Our understanding of what drives disease at the molecular level is expanding exponentially in this age of genomics and artificial intelligence. Yet we still face major challenges finding effective treatments for diseases ranging from cancer to dementia. How can biomedical research institutes bridge this gap? In the first lecture of Florida’s new Front Row Lecture Series, Peter Schultz, PhD, a pioneering chemist and president and CEO of Scripps Research, shares his vision for ensuring that discoveries made in biomedical research institutes reach patients and improve lives.

Presented: January 22, 2020

 

To view all Front Row Lectures from the California and Florida campuses click here.